The A4 Study: Stopping AD Before Symptoms Begin?
Reisa A. Sperling(Harvard University), Paul Aisen(University of California, San Diego), Michael Donohue(Alzheimer’s Disease Neuroimaging Initiative), Jason Karlawish(University of Pennsylvania), Dorene M. Rentz(Brigham and Women's Hospital), David P. Salmon(University of California San Diego), Keith A. Johnson(Brigham and Women's Hospital)
Cited by 773
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k